TY - JOUR
T1 - High-quality identification of volatile organic compounds (VOCs) originating from breath
AU - Arulvasan, Wisenave
AU - Chou, Hsuan
AU - Greenwood, Julia
AU - Ball, Madeleine L.
AU - Birch, Owen
AU - Coplowe, Simon
AU - Gordon, Patrick
AU - Ratiu, Andreea
AU - Lam, Elizabeth
AU - Hatch, Ace
AU - Szkatulska, Monika
AU - Levett, Steven
AU - Mead, Ella
AU - Charlton-Peel, Chloe
AU - Nicholson-Scott, Louise
AU - Swann, Shane
AU - van Schooten, Frederik Jan
AU - Boyle, Billy
AU - Allsworth, Max
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Introduction: Volatile organic compounds (VOCs) can arise from underlying metabolism and are detectable in exhaled breath, therefore offer a promising route to non-invasive diagnostics. Robust, precise, and repeatable breath measurement platforms able to identify VOCs in breath distinguishable from background contaminants are needed for the confident discovery of breath-based biomarkers. Objectives: To build a reliable breath collection and analysis method that can produce a comprehensive list of known VOCs in the breath of a heterogeneous human population. Methods: The analysis cohort consisted of 90 pairs of breath and background samples collected from a heterogenous population. Owlstone Medical’s Breath Biopsy® OMNI® platform, consisting of sample collection, TD-GC-MS analysis and feature extraction was utilized. VOCs were determined to be “on-breath” if they met at least one of three pre-defined metrics compared to paired background samples. On-breath VOCs were identified via comparison against purified chemical standards, using retention indexing and high-resolution accurate mass spectral matching. Results: 1471 VOCs were present in > 80% of samples (breath and background), and 585 were on-breath by at least one metric. Of these, 148 have been identified covering a broad range of chemical classes. Conclusions: A robust breath collection and relative-quantitative analysis method has been developed, producing a list of 148 on-breath VOCs, identified using purified chemical standards in a heterogenous population. Providing confirmed VOC identities that are genuinely breath-borne will facilitate future biomarker discovery and subsequent biomarker validation in clinical studies. Additionally, this list of VOCs can be used to facilitate cross-study data comparisons for improved standardization.
AB - Introduction: Volatile organic compounds (VOCs) can arise from underlying metabolism and are detectable in exhaled breath, therefore offer a promising route to non-invasive diagnostics. Robust, precise, and repeatable breath measurement platforms able to identify VOCs in breath distinguishable from background contaminants are needed for the confident discovery of breath-based biomarkers. Objectives: To build a reliable breath collection and analysis method that can produce a comprehensive list of known VOCs in the breath of a heterogeneous human population. Methods: The analysis cohort consisted of 90 pairs of breath and background samples collected from a heterogenous population. Owlstone Medical’s Breath Biopsy® OMNI® platform, consisting of sample collection, TD-GC-MS analysis and feature extraction was utilized. VOCs were determined to be “on-breath” if they met at least one of three pre-defined metrics compared to paired background samples. On-breath VOCs were identified via comparison against purified chemical standards, using retention indexing and high-resolution accurate mass spectral matching. Results: 1471 VOCs were present in > 80% of samples (breath and background), and 585 were on-breath by at least one metric. Of these, 148 have been identified covering a broad range of chemical classes. Conclusions: A robust breath collection and relative-quantitative analysis method has been developed, producing a list of 148 on-breath VOCs, identified using purified chemical standards in a heterogenous population. Providing confirmed VOC identities that are genuinely breath-borne will facilitate future biomarker discovery and subsequent biomarker validation in clinical studies. Additionally, this list of VOCs can be used to facilitate cross-study data comparisons for improved standardization.
KW - Breath analysis
KW - Breathomics
KW - Metabolome
KW - Non-invasive biomarkers
KW - Volatile metabolites
KW - Volatile organic compounds (VOCs)
U2 - 10.1007/s11306-024-02163-6
DO - 10.1007/s11306-024-02163-6
M3 - Article
SN - 1573-3882
VL - 20
JO - Metabolomics
JF - Metabolomics
IS - 5
M1 - 102
ER -